journal article·2024-03-20Open access

A Comprehensive Study on Folate-Targeted Mesoporous Silica Nanoparticles Loaded with 5-Fluorouracil for the Enhanced Treatment of Gynecological Cancers

Aliyah Almomen, Adel Alhowyan

Abstract

Background: Gynecological cancers are a significant public health concern, accounting for 40% of all cancer incidence and 30% of deaths in women. 5-Fluorouracil (5-FU) can be used with chemotherapy to improve treatment in advanced-stage gynecological cancer. Mesoporous silica nanoparticles (MSNs) can improve drug effectiveness and reduce toxicity. Folic acid can target folate receptors in epithelial malignancies like ovarian and cervical cancer. Methods: The mixture of MSN-NH2 was synthesized by dissolving N-lauroylsarcosine sodium in a water–ethanol mixture, adding APTES and TEOS, and heating at 80 °C for 18 h, before being fully characterized. The drug is loaded into a 5-FU solution and functionalized with folate. The drug release mechanism, as well as ex vivo intestinal permeation from MSN-NH2 formulations, was tested. The cell viability study of the nanoparticles was evaluated in various cancer cell lines, and the cellular uptake was measured indirectly using HPLC. Results: The study analyzed the amine content, propylamine loading, and drug loading capacity of MSN-NH2 nanoparticles. It found that the loading of propylamine was around 0.733 mmol/g, and the surface density was 0.81 molecules/nm. The study also showed that the surface decoration of MSN-NH2 with folic acid was successfully achieved. The release rate of 5-FU from MSN-NH2 was slow and controlled, with a slower rate at pH 5.5. The study found that the amin surface functionalization of MSN-NH2 nanoparticles can reduce potential toxicity in ovarian and cervical cancer cells. Conclusions: Based on the results, the encapsulation of 5-FU and functionalization of MSN-NH2 with folic acid can serve as potential carriers for 5-FU in treating gynecological cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Plant-Derived Bioactive Compounds · Chemotherapy-induced cardiotoxicity and mitigation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia

Funding

Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia

References (98)

Show source-provided references
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries10.3322/caac.21660 ↗
2. Fowler, J.R., Maani, E.V., Dunton, C.J., and Jack, B.W. (2023). Cervical Cancer, StatPearls.
3. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer10.1136/ijgc-2021-003001 ↗
4. Huang, J., Chan, W.C., Ngai, C.H., Lok, V., Zhang, L., Lucero-Prisno, D.E., Xu, W., Zheng, Z.J., Elcarte, E., and Withers, M. (2022). Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study. Cancers, 14.10.3390/cancers14092230 ↗
5. Ovarian cancer. Survival and treatment differences by age10.1002/cncr.2820710206 ↗
6. National Cancer Institute (2023, August 01). Cancer Stat Facts: Ovarian Cancer, Available online: https://seer.cancer.gov/statfacts/html/ovary.html.
7. (2023, July 07). Survival Rates for Ovarian Cancer. Available online: https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/survival-rates.html.
8. (2023, July 07). Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)—Health Professional Version, Available online: https://www.cancer.gov/types/ovarian/hp/ovarian-epithelial-treatment-pdq.
9. Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma10.1023/A:1008356010556 ↗
10. The efficacy of concurrent cisplatin and 5-flurouracil chemotherapy and radiation therapy for locally advanced cancer of the uterine cervix10.3802/jgo.2008.19.2.129 ↗
11. Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer10.1186/s13048-019-0506-4 ↗
12. Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics10.1016/j.addr.2008.02.010 ↗
13. Protamine-carboxymethyl cellulose magnetic nanocapsules for enhanced delivery of anticancer drugs against drug resistant cancers10.1016/j.nano.2015.01.005 ↗
14. Functionalization of hollow mesoporous silica nanoparticles for improved 5-FU loading10.1155/2015/872035 ↗
15. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery10.1177/0885328217724638 ↗
16. Galactosylated chitosan-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery10.1098/rsos.181027 ↗
17. Chitosan-folate coated mesoporous silica nanoparticles as a smart and pH-sensitive system for curcumin delivery10.1039/C6RA23182A ↗
18. Package delivered: Folate receptor-mediated transporters in cancer therapy and diagnosis10.1039/D3SC05539F ↗
19. Moodley, T., and Singh, M. (2019). Polymeric mesoporous silica nanoparticles for enhanced delivery of 5-fluorouracil in vitro. Pharmaceutics, 11.10.3390/pharmaceutics11060288 ↗
20. Hillery, A.M., Lloyd, A.W., and Swarbrick, J. (2002). Drug Delivery and Targeting: For Pharmacists and Pharmaceutical Scientists, CRC Press.
21. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles—Opportunities & challenges10.1039/c0nr00156b ↗
22. Targeted delivery of 5-aminolevulinic acid by multifunctional hollow mesoporous silica nanoparticles for photodynamic skin cancer therapy10.1021/acsami.5b03087 ↗
23. Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel10.2147/OTT.S113815 ↗
24. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux10.1016/j.ijpharm.2006.03.045 ↗
25. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery10.1021/nn800072t ↗
26. In vivo examination of folic acid-conjugated gold-silica nanohybrids as contrast agents for localized tumor diagnosis and biodistribution10.1021/acs.bioconjchem.8b00522 ↗
27. Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies10.1186/s13045-022-01320-5 ↗
28. Functional coating of liposomes using a folate–polymer conjugate to target folate receptors
29. Folate receptor alpha is associated with cervical carcinogenesis and regulates cervical cancer cells growth by activating ERK1/2/c-Fos/c-Jun10.1016/j.bbrc.2017.08.015 ↗
30. Almomen, A., El-Toni, A.M., Badran, M., Alhowyan, A., Abul Kalam, M., Alshamsan, A., and Alkholief, M. (2020). The Design of Anionic Surfactant-Based Amino-Functionalized Mesoporous Silica Nanoparticles and their Application in Transdermal Drug Delivery. Pharmaceutics, 12.10.3390/pharmaceutics12111035 ↗
31. Alhowyan, A.A., Kalam, M.A., Iqbal, M., Raish, M., El-Toni, A.M., Alkholief, M., Almomen, A.A., and Alshamsan, A. (2023). Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies. Molecules, 28.10.3390/molecules28031260 ↗
32. Optimization of 5-flurouracil solid-lipid nanoparticles: A preliminary study to treat colon cancer10.7150/ijms.7.398 ↗
33. 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: Evaluation of controlled release kinetics
34. Preparation and characterisation of 5-fluorouracil loaded PLGA nanoparticles for colorectal cancer therapy
35. Prolonged exposure of colon cancer cells to 5-fluorouracil nanoparticles improves its anticancer activity10.1016/j.jsps.2016.05.010 ↗
36. Eudragit S100 coated citrus pectin nanoparticles for colon targeting of 5-fluorouracil10.3390/ma8030832 ↗
37. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: Therapeutic efficacy evaluation
38. Layer-by-layer assembly of hyaluronic acid/carboxymethylchitosan polyelectrolytes on the surface of aminated mesoporous silica for the oral delivery of 5-fluorouracil10.1016/j.eurpolymj.2017.06.033 ↗
39. Chitosan coated sodium alginate–chitosan nanoparticles loaded with 5-FU for ocular delivery: In vitro characterization and in vivo study in rabbit eye10.1016/j.ejps.2012.08.008 ↗
40. Combination of therapy with 5-fluorouracil and cisplatin with electroporation in human ovarian carcinoma model in vitro10.1016/j.biopha.2014.05.005 ↗
41. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles10.3109/10717544.2013.875603 ↗
42. Synergistic effect of folate-conjugated polymers and 5-fluorouracil in the treatment of colon cancer10.1186/s12645-021-00104-9 ↗
43. Design of 5-fluorouracil (5-FU) loaded, folate conjugated peptide linked nanoparticles, a potential new drug carrier for selective targeting of tumor cells10.1039/C8MD00565F ↗
44. A pH-responsive bi-MIL-88B MOF coated with folic acid-conjugated chitosan as a promising nanocarrier for targeted drug delivery of 5-Fluorouracil10.3389/fphar.2023.1265440 ↗
45. Co-encapsulation of paclitaxel and 5-fluorouracil in folic acid-modified, lipid-encapsulated hollow mesoporous silica nanoparticles for synergistic breast cancer treatment10.1039/D2RA03718A ↗
46. Amino and quaternary ammonium group functionalized mesoporous silica: An efficient ion-exchange method to remove anionic surfactant from AMS10.1016/j.micromeso.2008.04.016 ↗
47. Validated high-performance liquid chromatographic technique for determination of 5-fluorouracil: Applications to stability studies and simulated colonic media10.1093/chromsci/47.7.558 ↗
48. Folate receptor targeting silica nanoparticle probe for two-photon fluorescence bioimaging10.1364/BOE.1.000453 ↗
49. Peretti, E., Miletto, I., Stella, B., Rocco, F., Berlier, G., and Arpicco, S. (2018). Strategies to obtain encapsulation and controlled release of pentamidine in mesoporous silica nanoparticles. Pharmaceutics, 10.10.3390/pharmaceutics10040195 ↗
50. Natural material-decorated mesoporous silica nanoparticle container for multifunctional membrane-controlled targeted drug delivery10.2147/IJN.S148438 ↗
51. Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends10.1016/j.carbpol.2011.03.045 ↗
52. Li, P., Wang, Y., Peng, Z., She, M.F., and Kong, L. (2010, January 22–26). Physichemical property and morphology of 5-fluorouracil loaded chitosan nanoparticles. Proceedings of the 2010 International Conference on Nanoscience and Nanotechnology, Sydney, Australia.10.1109/ICONN.2010.6045203 ↗
53. Facile preparation of multifunctional hollow silica nanoparticles and their cancer specific targeting effect10.1039/c3bm00007a ↗
54. Šuleková, M., Váhovská, L., Hudák, A., Žid, L., and Zeleňák, V. (2019). A Study of 5-fluorouracil desorption from mesoporous silica by RP-UHPLC. Molecules, 24.10.3390/molecules24071317 ↗
55. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
56. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: Current status and future perspectives10.2174/15680096113139990076 ↗
57. Thermosensitive progesterone hydrogel: A safe and effective new formulation for vaginal application10.1007/s11095-014-1616-8 ↗
58. Cionti, C., Taroni, T., Sabatini, V., and Meroni, D. (2021). Nanostructured oxide-based systems for the pH-triggered release of cinnamaldehyde. Materials, 14.10.3390/ma14061536 ↗
59. Tautomeric equilibria of 5-fluorouracil anionic species in water10.1021/jp1063879 ↗
60. Biowaiver monographs for immediate-release solid oral dosage forms: Folic acid10.1016/j.xphs.2017.08.007 ↗
61. Parın, F.N., Ullah, S., Yıldırım, K., Hashmi, M., and Kim, I.-S. (2021). Fabrication and characterization of electrospun folic acid/hybrid fibers: In vitro controlled release study and cytocompatibility assays. Polymers, 13.10.3390/polym13203594 ↗
62. Preparation and biological evaluation of radiolabeled-folate embedded superparamagnetic nanoparticles in wild-type rats10.1007/s10967-010-0661-y ↗
63. Evaluation of Surfactants-Assisted Folic Acid-Loaded Pectin Submicrospheres: Characterization and Hemocompatibility Assay10.1007/s12291-016-0549-x ↗
64. Stability of folic acid under several parameters10.1016/j.ejps.2016.08.045 ↗
65. Hyun, H., Park, M.H., Jo, G., Lee, B.Y., Choi, J.W., Chun, H.J., Kim, H.S., and Yang, D.H. (2021). Injectable glycol chitosan hydrogel containing folic acid-functionalized cyclodextrin-paclitaxel complex for breast cancer therapy. Nanomaterials, 11.10.3390/nano11020317 ↗
66. Quantification and stability determination of surface amine groups on silica nanoparticles using solution NMR10.1021/acs.analchem.8b02803 ↗
67. Tataurova, Y.N. (2014). Proton NMR Studies of Functionalized Nanoparticles in Aqueous Environments. [Ph.D. Thesis, University of Iowa].
68. Meisenheimer complex between 2,4,6-trinitrotoluene and 3-aminopropyltriethoxysilane and its use for a paper-based sensor10.1016/j.sbsr.2015.06.003 ↗
69. Autocatalytic synthesis of molecular-bridged silica aerogels with excellent absorption and super elasticity10.1039/C5RA19776G ↗
70. Data on the synthesis and mechanical characterization of polysiloxane-based urea-elastomers prepared from amino-terminated polydimethylsiloxanes and polydimethyl-methyl-phenyl-siloxane-copolymers10.1016/j.dib.2018.04.083 ↗
71. Synthesis, Optimization and Characterization of Folate-Chitosan Polymer Conjugate for Possible Oral Delivery of Macromolecular Drugs
72. Varshosaz, J., Hassanzadeh, F., Sadeghi Aliabadi, H., Nayebsadrian, M., Banitalebi, M., and Rostami, M. (2014). Synthesis and characterization of folate-targeted dextran/retinoic acid micelles for doxorubicin delivery in acute leukemia. BioMed Res. Int., 2014.10.1155/2014/525684 ↗
73. Synthesis and characterization of vincristine loaded folic acid–chitosan conjugated nanoparticles
74. Fabrication and characterization of a folic acid-bound 5-fluorouracil loaded quantum dot system for hepatocellular carcinoma targeted therapy10.1039/C8RA01025K ↗
75. Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers10.3109/10717544.2013.845861 ↗
76. Influence of surface functionalization on the hydrophilic character of mesoporous silica nanoparticles10.1039/C5CP00552C ↗
77. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum10.1016/j.ijpharm.2005.04.004 ↗
78. In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil10.1211/jpp.60.5.0007 ↗
79. Siwowska, K., Schmid, R.M., Cohrs, S., Schibli, R., and Müller, C. (2017). Folate receptor-positive gynecological cancer cells: In vitro and in vivo characterization. Pharmaceuticals, 10.10.3390/ph10030072 ↗
80. Nano drug delivery strategy of 5-fluorouracil for the treatment of colorectal cancer10.1016/j.jcrpr.2017.02.002 ↗
81. Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates10.3109/1061186X.2014.921924 ↗
82. Pattni, B.S., and Torchilin, V.P. (2015). Targeted Drug Delivery: Concepts and Design, Springer.
83. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield10.1038/s41467-019-08902-x ↗
84. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles10.1128/AAC.06049-11 ↗
85. Inclusion of Aceclofenac in Mesoporous Silica Nanoparticles: Drug Release Study and Statistical Optimization of Encapsulation Efficiency by Response Surface Methodology10.1080/10667857.2019.1624301 ↗
86. Absorption of 5-fluorouracil and related pyrimidines in rat small intestine10.1042/cs0720705 ↗
87. Changes in intestinal absorption of 5-fluorouracil-treated rats10.1111/j.1600-0773.1999.tb01060.x ↗
88. Nunes, R., Silva, C., and Chaves, L. (2016). Concepts and Models for Drug Permeability Studies, Elsevier.
89. Physicochemical properties and in vitro intestinal permeability properties and intestinal cell toxicity of silica particles, performed in simulated gastrointestinal fluids10.1016/j.bbagen.2013.12.014 ↗
90. Amine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungs10.1016/j.toxlet.2015.11.006 ↗
91. Effect of folate on the proliferation of human cervical cancer cell and relationship with HPV16
92. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells10.1021/ja0645943 ↗
93. A distinct endocytic mechanism of functionalized-silica nanoparticles in breast cancer stem cells10.1038/s41598-017-16591-z ↗
94. Pharmacokinetic study and clinical evaluation of a slow-release 5-fluorouracil implant in pancreatic cancer patients10.1097/CAD.0000000000000293 ↗
95. In vitro and in vivo reversal of resistance to 5-fluorouracil in colorectal cancer cells with a novel stealth double-liposomal formulation10.1038/sj.bjc.6603970 ↗
96. Colon targeted drug delivery systems: A review on primary and novel approaches10.5001/omj.2010.24 ↗
97. Dulin, W. (2010). Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice, John Wiley & Sons.
98. Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping10.1016/j.colsurfb.2016.10.049 ↗